Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Opioid-Induced Constipation 1Neoplasms 1Intestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cancer Pain 1

Interventions

Propofol 3Oxaliplatin 3Morphine 3Fentanyl 3Sevoflurane 2Ropivacaine 2Fluorouracil 2Capecitabine 2Bupivacaine 2Bevacizumab 2Acetaminophen 2polyethylene glycol 3350 1oxycodone-acetaminophen 1gatorade 1fish oil triglycerides 1Vitamin D 1Tranexamic Acid 1Tramadol 1Tegafur 1Sodium Chloride 1Simethicone 1Saline Solution 1Rivaroxaban 1Polyethylene Glycols 1Pirinitramide 1Panitumumab 1Orphenadrine 1Neuroleptanalgesia 1Midazolam 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Colonic Neoplasms × Polyethylene Glycols × Clear all
NCT01170754 2017-09-13

Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

Temple University

Phase 4 Completed
136 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡